[Aminoglutethimide - a new drug for the after care in breast cancer].
Aminoglutethimide is an inhibitor of various steroid hydroxylation reactions in the adrenal gland, the ovary, the testis and the placenta; furthermore, the extraglandular estrogen synthesis is inhibited by blocking the aromatase in the subcutaneous fatty tissue.
D000616:Aminoglutethimide / Q000378:metabolism / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000556:secondary; D003907:Dexamethasone / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006207:Half-Life; D006801:Humans; D008408:Mastectomy
D000616:Aminoglutethimide; D003907:Dexamethasone
Aminoglutethimid - ein neues Medikament zur Nachbehandlung beim Mammakarzinom.